Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis

Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers

Expansion of gamma delta T cells – a short review on bisphosphonate and K562-based methods

Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells

1 2